Intravenous immunoglobulin: A potential treatment for the post-acute sequelae of SARS-Cov-2 infection?

Bosn J Basic Med Sci. 2022 Jul 29;22(4):660-664. doi: 10.17305/bjbms.2021.6901.
No abstract available

Publication types

  • Letter

MeSH terms

  • COVID-19 Drug Treatment*
  • COVID-19* / complications
  • Humans
  • Immunoglobulins, Intravenous / therapeutic use
  • Post-Acute COVID-19 Syndrome
  • SARS-CoV-2

Substances

  • Immunoglobulins, Intravenous